Law ❯ Corporate Law ❯ Securities Regulation

Class Action Lawsuits

Legal Representation Investor Protection Investor Compensation Legal Recourse Misleading Statements Plaintiff Representation Investor Claims Investor Advocacy

Atara Biotherapeutics Hit With Investor Class Action Over FDA Setbacks

Shareholders seek recovery after alleged misstatements about tabelecleucel’s approval path.

New Kyndryl Class Action Filing Expands Investor Window, Alleges Inflated Cash Flow

Richtech Robotics Faces Wave of Securities Suits Over Microsoft Claims as Lead Plaintiff Deadline Nears

Sallie Mae Investors Face Feb. 17 Deadline to Seek Lead in Securities Fraud Suit

CarMax Investors Face Jan. 2 Deadline in Securities Suit Over Tariff-Linked Demand, Credit Risks

CarMax Securities Suits Intensify as Jan. 2 Lead‑Plaintiff Deadline Nears

Inspire Medical Investors Face Jan. 5 Deadline in Lawsuits Over Troubled Inspire V Rollout

Investor Firms Step Up Bid to Lead CarMax Securities Case as Jan. 2 Deadline Looms

Law Firms Press Stride Investors to Lead Securities Case Alleging ‘Ghost Students,’ Tech Failure

Blue Owl Investors Face Feb. 2 Deadline in Securities Class Action Over BDC Redemption Disclosures

Freeport-McMoRan Investors Urged to Seek Lead Role in Grasberg Safety Class Action

LifeMD Securities Case Reaches Lead-Plaintiff Deadline as Firms Court Investors

Semler Scientific Investors Urged to Act as Oct. 28 Lead-Plaintiff Deadline Nears in DOJ Disclosure Suit

Lantheus Faces Investor Class Actions Over Pylarify Pricing and Competition Claims

Charter Securities Case Advances as Lead-Plaintiff Deadline Looms for Investors